论文部分内容阅读
我国的慢性乙型肝炎 (下简称慢乙肝 )表面抗原 (ＨＢｓＡｇ)携带者约占9.75 % ,根据推算 ,慢乙肝患者约 30 0 0万人〔1〕。至今用于慢乙肝治疗的药物和疗法虽然很多 ,但尚无满意的治疗药物和方法。 2 0世纪 80年代初 ,我们在慢乙肝临床治疗研究中发现抗乙肝胎盘转移因子 (ＰＳ
China’s chronic hepatitis B (hereinafter referred to as chronic hepatitis B) surface antigen (HBsAg) carriers account for about 9.75%, according to projections, about 30 million patients with chronic hepatitis B [1]. Although there are many drugs and therapies for chronic hepatitis B so far, there are no satisfactory remedies and methods. In the early 1980s, we found in anti-hepatitis B placental transfer factor (PS)